BioSpace News Archive

Business

Vir Biotechnology Builds Pipeline, Capabilities, And Lays Out Strategy To Address Serious Infectious Diseases

Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc., and Visterra, Inc., as well as four leading academic research institutions.

October 18, 2017
·
9 min read
U.S. Patent Granted For Benitec Hepatitis B Program

Benitec is pleased to announce that a new patent relating to the Company’s hepatitis B program has been issued in the United States.

October 18, 2017
·
3 min read
Biotech Beach

Trovagene’s PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga® (abiraterone acetate) in Castration Resistant Prostate Cancer Tumor Cells

Trovagene today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga - J&J)/

October 18, 2017
·
7 min read
Genetown

Respiratory Motion is Excited to Announce the Launch of the Latest ExSpiron 1Xi Respiratory Monitor

Respiratory Motion announced today its plans to launch the newest version of its ExSpiron 1Xi Minute Ventilation (MV) Monitor at the ASA in Boston, October 21-25 following recent FDA clearance.

October 18, 2017
·
3 min read
Aytu BioScience Announces Uplisting to The NASDAQ Capital Market

Aytu BioScience today announced that its shares of common stock were approved for listing on The NASDAQ Capital Market.

October 18, 2017
·
4 min read
Biotech Bay

Blade Therapeutics Announces Selection Of A Clinical Development Candidate And Funding Of The Second Tranche For Its Series B Financing

Blade Therapeutics announced that it has nominated a clinical development candidate for its lead program focused on small molecule inhibitors that selectively target certain intracellular cysteine proteases.

October 18, 2017
·
2 min read
Biotech Bay

10x Genomics Enables High-Volume Studies By Providing More Affordable Solutions For Whole Genome And Exome Analysis

10x Genomics announced more affordable pricing for their Chromium Genome, Exome and de novo Assembly Solutions.

October 18, 2017
·
5 min read
Drug Development

Revance Completes Patient Enrollment In Phase 2 Program For RT002 Injectable In The Management Of Plantar Fasciitis

Revance Therapeutics announced it has completed enrollment of patients in the Company’s Phase 2 program investigating the use of DaxibotulinumtoxinA for Injection (RT002) for the management of plantar fasciitis.

October 18, 2017
·
6 min read